Canagliflozin and metformin and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Canagliflozin and metformin and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canagliflozin / metformin
Brand name: Invokamet, Invokamet XR
Synonyms: Canagliflozin and Metformin
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canagliflozin and metformin-Moxifloxacin
- Canagliflozin and metformin-Moxifloxacin (Systemic)
- Canagliflozin and metformin-Moxifloxacin Hydrochloride
- Canagliflozin and metformin-Moxifloxacin Injection
- Canagliflozin and metformin-Moxifloxacin Intravenous
- Canagliflozin and metformin-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Canagliflozin and Metformin Extended-Release Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Canagliflozin and Metformin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Canakinumab
- Moxetumomab pasudotox-tdfk Intravenous-Canakinumab Subcutaneous
- Moxetumomab pasudotox-tdfk Intravenous-Canasa
- Moxetumomab pasudotox-tdfk Intravenous-Canasa Pac rectal